On Tuesday, the Vetr crowd downgraded their rating for Merck & Co., Inc. MRK from 2 stars (Sell), issued two weeks ago, to 1.5 stars (Strong Sell). Still, the Vetr crowd remained confident in the stock as 75 percent of user ratings were bullish.
There have been some signs of life in Merck's price over the past couple of days following a bit of a selloff last week where the price dropped nearly $4. Part of this movement could be due to the rollercoaster of news regarding Merck's successful trial of a potential Ebola vaccine.
The stock closed at $59.27.
See how crowdsourced ratings could help you time the market.
Currently, the vetr crowd's average target price for the stock is down at $52.27, well below the average analyst price of $65.20. Less than 2 percent of Vetr users are holding MRK in their watch-lists.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
